CN104013709B - A kind of anticancer righting decoction liquid for oral administration - Google Patents

A kind of anticancer righting decoction liquid for oral administration Download PDF

Info

Publication number
CN104013709B
CN104013709B CN201410288392.6A CN201410288392A CN104013709B CN 104013709 B CN104013709 B CN 104013709B CN 201410288392 A CN201410288392 A CN 201410288392A CN 104013709 B CN104013709 B CN 104013709B
Authority
CN
China
Prior art keywords
parts
radix
radix angelicae
righting
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410288392.6A
Other languages
Chinese (zh)
Other versions
CN104013709A (en
Inventor
王在峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410288392.6A priority Critical patent/CN104013709B/en
Publication of CN104013709A publication Critical patent/CN104013709A/en
Application granted granted Critical
Publication of CN104013709B publication Critical patent/CN104013709B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Anticancer righting decoction liquid for oral administration of the present invention, it is characterized in that: be made up of the raw material of following parts by weight: Radix Codonopsis 74-94 part, Rhizoma Atractylodis Macrocephalae (parched) 60-80 part, Poria 60-80 part, fry Pericarpium Citri Reticulatae 60-80 part, Radix Astragali 190-230 part, Radix Angelicae Sinensis 60-80 part, Radix Angelicae Dahuricae 60-80 part, Herba Scutellariae Barbatae 95-115 part, Herba Hedyotidis Diffusae 95-115 part, fries Nidus Vespae 36-48 part, Squama Manis 74-94 part.The invention has the beneficial effects as follows, good effect, instant effect, to have no side effect.Through the clinical practice of more than ten years, this Chinese medicine use safety, convenience, easy, no pain, avirulence, without anaphylaxis, excellent curative.

Description

A kind of anticancer righting decoction liquid for oral administration
Technical field
The invention belongs to Chinese medicine composition field, relate to a kind of anticancer righting decoction liquid for oral administration, carcinoma, especially has good effect to digestive tract, respiratory tract neoplasms and lymphoma.
Background technology
At present, along with the deterioration of air quality, huge operating pressure and bad life habits, the people obtaining cancer gets more and more, but the curative effect of medication for the treatment of is undesirable, and the course for the treatment of is long, and price is high, causes puzzlement to extensive patients.
Summary of the invention
The present invention, in order to make up the deficiencies in the prior art, provides a kind of good effect, instant effect, for oral administration anticancer righting decoction liquid that price is low.
The present invention is achieved through the following technical solutions:
Anticancer righting decoction liquid for oral administration of the present invention, it is characterized in that: be made up of the raw material of following parts by weight: Radix Codonopsis 74-94 part, Rhizoma Atractylodis Macrocephalae (parched) 60-80 part, Poria 60-80 part, fry Pericarpium Citri Reticulatae 60-80 part, Radix Astragali 190-230 part, Radix Angelicae Sinensis 60-80 part, Radix Angelicae Dahuricae 60-80 part, Herba Scutellariae Barbatae 95-115 part, Herba Hedyotidis Diffusae 95-115 part, fries Nidus Vespae 36-48 part, Squama Manis 74-94 part.
Anticancer righting decoction liquid for oral administration of the present invention, also comprises the crude drug of following parts by weight: Rhizoma Dioscoreae Bulbiferae 74-94 part, Rhizoma Polygonati 116-136 part, Radix Salviae Miltiorrhizae 74-94 part, eupolyphaga 60-80 part, Pseudobulbus cremastrae seu pleiones 60-80 part.
Anticancer righting decoction liquid for oral administration of the present invention, preferred version is, is made up of the raw material of following parts by weight: Radix Codonopsis 84 parts, Rhizoma Atractylodis Macrocephalae (parched) 70 parts, Poria 70 parts, fries Pericarpium Citri Reticulatae 70 parts, the Radix Astragali 210 parts, Radix Angelicae Sinensis 70 parts, the Radix Angelicae Dahuricae 70 parts, Herba Scutellariae Barbatae 105 parts, Herba Hedyotidis Diffusae 105 parts, fry 42 parts, Nidus Vespae, Squama Manis 84 parts.
Anticancer righting decoction liquid for oral administration of the present invention, also comprises the crude drug of following parts by weight: Rhizoma Dioscoreae Bulbiferae 84 parts, Rhizoma Polygonati 126 parts, Radix Salviae Miltiorrhizae 84 parts, eupolyphaga 70 parts, Pseudobulbus cremastrae seu pleiones 70 parts.
In formula, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, the Radix Astragali, Rhizoma Polygonati invigorating the spleen to benefit the lung, promote the production of body fluid and nourish blood, have deficiency of both the splenic and pulmonary QI for tumor patient more, the card of gas Tianjin two wound, the first righting therefore what is called will be got rid of evils; Poria, Pericarpium Citri Reticulatae diuretic, spleen invigorating, calms the nerves, thus improves the diet of patient, enhancing immunity, eliminates the stress that tumor is brought; The enriching blood of Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, eupolyphaga, invigorate blood circulation, pain relieving, tumor patient anemia, blood viscosity are high to improve for intestine moistening function, cancer pain and being hard and dry.Pseudobulbus cremastrae seu pleiones, Herba Scutellariae Barbatae, Herba Hedyotidis Diffusae, Nidus Vespae, Radix Angelicae Dahuricae heat-clearing and toxic substances removing, dispel the wind counteracting toxic substances antitumor action; Squama Manis is invigorated blood circulation Xiao Disorder antitumor.
Poria: i.e. Poria, promoting diuresis to eliminate damp pathogen, invigorating middle warmer spleen invigorating, mind tranquilizing and the heart calming.
Eupolyphaga: i.e. eupolyphoge sinensis, removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones.For injured bone, blood stasis amenorrhea, lump in the abdomen mass in the abdomen.
Rhizoma Polygonati: there is spleen reinforcing, the effect of the lung moistening and production of body fluid promoting.
Pseudobulbus cremastrae seu pleiones: be the bulb of liliaceous plant Tulipa edulis and T.iliensis.There is heat-clearing and toxic substances removing, effect of eliminating carbuncle eliminating stagnation.
Herba Scutellariae Barbatae: there is heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, the function such as anticancer.
Herba Hedyotidis Diffusae: primary efficacy is heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.Outstanding kind treatment all kinds inflammation.
Nidus Vespae: dispel the wind, counteracting toxic substances, parasite killing, pain relieving, antiallergic.
Rhizoma Dioscoreae Bulbiferae: be the tuber of Dioscoreaceae plant Dioscorea bulbifera L..There is eliminating stagnation to disappear the effects such as wart, heat-clearing and toxic substances removing, cooling blood for hemostasis.
Preparation method: decocting method.
Usage and dosage: every day services once sooner or later, oral, takes potion in 7 days.
The invention has the beneficial effects as follows,
1. raw material sources enriches, and cheap, small investment of production equipment, is easily accepted by extensive patients.
2. through the clinical practice of more than ten years, this Chinese medicine use safety, convenience, easy, no pain, avirulence, without anaphylaxis, excellent curative.
3. clear and definite for diagnosis, be unwilling chemicotherapy and operation, or because of older, body constitution is poor, can not chemicotherapy and operation.And even during chemicotherapy and perioperatively all can take this product.And this product can also reduce the side reaction that chemicotherapy and operation bring, improve immunity, strengthen treatment curative effect.
4. the work for ratio of Chinese herbal medicine in community-sponsored medical insurance is higher, also just significantly reduces the financial difficulties of tumor patient, also can make major contribution for Chinese Chinese medicine.
5. effective percentage is up to 96% in clinical practice for medicinal liquid of the present invention, and most of patient can obviously be benefited.Finally reach and allow patient improve life quality, improve life span, reduce patient painful, reduce the burden of society and household.
Detailed description of the invention
Embodiment 1
Anticancer righting decoction liquid for oral administration of the present invention, is made up of the raw material of following weight: Radix Codonopsis 84g, Rhizoma Atractylodis Macrocephalae (parched) 70g, Poria 70g, fries Pericarpium Citri Reticulatae 70g, Radix Astragali 210g, Radix Angelicae Sinensis 70g, Radix Angelicae Dahuricae 70g, Herba Scutellariae Barbatae 105g, Herba Hedyotidis Diffusae 105g, fry Nidus Vespae 42g, Squama Manis 84g.
Preparation method of the present invention:
1. roguing: by impurity removing in above-mentioned formula material, will eluriate if desired, remove earth.
2. invade bubble: can ceramic cylinder be adopted, the containers such as rustless steel, invade bubble with cold water, do not have crude drug to be advisable.Invading the bubble time should be no less than 30 minutes.
3. decocting: through invading the raw material soaked, putting into boiling machine and decocting, first time adds the soak by water 2 hours of 8 times of weight, and second time adds the soak by water 1.5 hours of 6 times of weight, after decocting, the medicinal liquid of twice is filtered and merges.
4. sterilizing: medicinal liquid is through decocting, and most of harmful bacteria, to kill, is ensure product long storage time, after the fill of polyethylene Chinese medicine bag, Killing germs by microwave 1 minute immediately while hot.Namely " anticancer righting decoction liquid " safely and effectively of the present invention product is obtained.
Usage and dosage: every day services once sooner or later, and above medicine is the dose of 7 days.
Embodiment 2
Anticancer righting decoction liquid for oral administration of the present invention, is made up of the raw material of following weight: Radix Codonopsis 74, Rhizoma Atractylodis Macrocephalae (parched) 60g, Poria 60g, fries Pericarpium Citri Reticulatae 60g, Radix Astragali 190g, Radix Angelicae Sinensis 60g, Radix Angelicae Dahuricae 60g, Herba Scutellariae Barbatae 95g, Herba Hedyotidis Diffusae 95g, fry Nidus Vespae 36g, Squama Manis 74g.
All the other are identical with embodiment 1.
Embodiment 3
Anticancer righting decoction liquid for oral administration of the present invention, is made up of the raw material of following weight: Radix Codonopsis 94g, Rhizoma Atractylodis Macrocephalae (parched) 80g, Poria 80g, fries Pericarpium Citri Reticulatae 80g, Radix Astragali 230g, Radix Angelicae Sinensis 80g, Radix Angelicae Dahuricae 80g, Herba Scutellariae Barbatae 115g, Herba Hedyotidis Diffusae 115g, fry Nidus Vespae 48g, Squama Manis 94g.
All the other are identical with embodiment 1.
Embodiment 4 clinical verification
Clinical observation: the present invention carries out clinical observation treatment to 300 routine patients, 34 to 83 years old ages, wherein gastric cancer, each 100 examples of pulmonary carcinoma, malignant lymphoma, the course of disease 1 year-3 years is not etc.Gastric cancer is glutted after showing as Upper abdominal pain, feed, appetite declines, weak, chest pain, hematemesis, melena etc.; Pulmonary carcinoma shows as cough, sputum mixed with blood or spitting of blood, chest pain, uncomfortable in chest, out of breath, hoarseness etc.; Malignant lymphoma main manifestations is Silent Neuritis lymphadenectasis, hepatosplenomegaly, and each histoorgan of whole body all can be got involved, the heat that occurs together, night sweat, become thin, the General Symptoms such as pruritus, anemia, dermatosis.Every day services once sooner or later, within seven days, eats up the medicinal liquid of above-described embodiment 1,2 or 3 medicine.Surrounding is a course for the treatment of.
(1) efficacy assessment standard:
Cure: Clinical symptom and sign disappears, functional activity recovers normal, and every Index for examination recovers normal.
Effective: clinical symptoms is clearly better or takes a turn for the better, every Index for examination part is normal, part is abnormal or Index for examination takes a turn for the better.
Invalid: Clinical symptom and sign is without improvement, and every Index for examination is still abnormal.
(2) therapeutic effect:
Clinical cure 261 example, account for 87%, gastric cancer, pulmonary carcinoma, malignant lymphoma are respectively 70,101,90; Effective 33 examples, account for 11%, gastric cancer, pulmonary carcinoma, malignant lymphoma are respectively 10,8,15; Invalid 6 examples, account for 2%; Total effective rate 98%.Wherein, 1-2 the course for the treatment of cures 10 examples, and 3-4 the course for the treatment of cures 40 examples, and 5-6 the course for the treatment of cures 100 examples, and 7-8 the course for the treatment of cures 111 examples.
Case one: go into business so-and-so, man, 83 years old, in October, 2007 suffered from pulmonary carcinoma, because of older, have chronic bronchitis medical history, cardio-pulmonary function is poor, and operation and chemicotherapy all can not do, and family members are patient suffering soon, after taking anticancer righting soup, conditions of patients getting well gradually is turned over, and adhere to drinking medicine, patients symptomatic improves.
Case two: king so-and-so, man, 43 years old, in April, 2009 suffered from hepatocarcinoma; pathological changes has transfer not perform an operation, row interventional therapy, analysis expert: the state of an illness is difficult to control, patient was oral at that time anticancer righting soup; some months has been gone over, not only the state of an illness not progress, and was comparatively before clearly better.Patient has had raw hope.
Case three: Zhang, female, 63 years old, in February, 2011 got a cancer of the stomach, row operative treatment, Subtotal gastrectomy, postoperative patient feed is few, and abdominal distention, becomes thin, should postoperative chemotherapy, can not chemotherapy.After anticancer righting soup, patients symptomatic improves, and also can accept chemotherapy, and chemotherapy side effect is very little, the very fast rehabilitation of patient.
Embodiment 5
Anticancer righting decoction liquid for oral administration of the present invention, is made up of the raw material of following weight: Radix Codonopsis 74, Rhizoma Atractylodis Macrocephalae (parched) 60g, Poria 60g, fries Pericarpium Citri Reticulatae 60g, Radix Astragali 190g, Radix Angelicae Sinensis 60g, Radix Angelicae Dahuricae 60g, Herba Scutellariae Barbatae 95g, Herba Hedyotidis Diffusae 95g, fries Nidus Vespae 36g, Squama Manis 74g, Rhizoma Dioscoreae Bulbiferae 74g, Rhizoma Polygonati 116g, Radix Salviae Miltiorrhizae 74g, eupolyphaga 60g, Pseudobulbus cremastrae seu pleiones 60g.
All the other are identical with embodiment 1.
Embodiment 6
Anticancer righting decoction liquid for oral administration of the present invention, is made up of the raw material of following weight: Radix Codonopsis 74, Rhizoma Atractylodis Macrocephalae (parched) 60g, Poria 60g, fries Pericarpium Citri Reticulatae 60g, Radix Astragali 190g, Radix Angelicae Sinensis 60g, Radix Angelicae Dahuricae 60g, Herba Scutellariae Barbatae 95g, Herba Hedyotidis Diffusae 95g, fries Nidus Vespae 36g, Squama Manis 74g, Rhizoma Dioscoreae Bulbiferae 94g, Rhizoma Polygonati 136g, Radix Salviae Miltiorrhizae 94g, eupolyphaga 80g, Pseudobulbus cremastrae seu pleiones 80g.
All the other are identical with embodiment 1.
Embodiment 7
Anticancer righting decoction liquid for oral administration of the present invention, is made up of the raw material of following weight: Radix Codonopsis 84g, Rhizoma Atractylodis Macrocephalae (parched) 70g, Poria 70g, fries Pericarpium Citri Reticulatae 70g, Radix Astragali 210g, Radix Angelicae Sinensis 70g, Radix Angelicae Dahuricae 70g, Herba Scutellariae Barbatae 105g, Herba Hedyotidis Diffusae 105g, fries Nidus Vespae 42g, Squama Manis 84g, Rhizoma Dioscoreae Bulbiferae 84g, Rhizoma Polygonati 126g, Radix Salviae Miltiorrhizae 84g, eupolyphaga 70g, Pseudobulbus cremastrae seu pleiones 70g.
Embodiment 8 clinical verification
Clinical observation: the present invention carries out clinical observation treatment to 210 routine patients, 34 to 83 years old ages, wherein gastric cancer, each 70 examples of pulmonary carcinoma, malignant lymphoma, the course of disease 1 year-3 years is not etc.Gastric cancer is glutted after showing as Upper abdominal pain, feed, appetite declines, weak, chest pain, hematemesis, melena etc., pulmonary carcinoma shows as cough, sputum mixed with blood or spitting of blood, chest pain, uncomfortable in chest, out of breath, hoarseness etc., malignant lymphoma main manifestations is Silent Neuritis lymphadenectasis, hepatosplenomegaly, the each histoorgan of whole body all can be got involved, the heat that occurs together, night sweat, become thin, the General Symptoms such as pruritus, anemia, dermatosis.Every day services once sooner or later, within seven days, eats up the medicinal liquid of above-described embodiment 5,6 or 7 medicine.Surrounding is a course for the treatment of.
(3) efficacy assessment standard:
Cure: Clinical symptom and sign disappears, functional activity recovers normal, and every Index for examination recovers normal.
Effective: clinical symptoms is clearly better or takes a turn for the better, every Index for examination part is normal, part is abnormal, or Index for examination takes a turn for the better.
Invalid: Clinical symptom and sign is without improvement, and every Index for examination is still abnormal.
(4) therapeutic effect:
Clinical cure 187 example, account for 89%, gastric cancer, pulmonary carcinoma, malignant lymphoma are respectively 60,81,46; Effective 20 examples, account for 10%, gastric cancer, pulmonary carcinoma, malignant lymphoma are respectively 7,7,6; Invalid 3 examples, account for 1%; Total effective rate 99%.Wherein, 1-2 the course for the treatment of cures 12 examples, and 3-4 the course for the treatment of cures 41 examples, and 5-6 the course for the treatment of cures 70 examples, and 7-8 the course for the treatment of cures 87 examples.

Claims (4)

1. an anticancer righting decoction liquid for oral administration, it is characterized in that: be made up of the crude drug of following parts by weight: Radix Codonopsis 74-94 part, Rhizoma Atractylodis Macrocephalae (parched) 60-80 part, Poria 60-80 part, fry Pericarpium Citri Reticulatae 60-80 part, Radix Astragali 190-230 part, Radix Angelicae Sinensis 60-80 part, Radix Angelicae Dahuricae 60-80 part, Herba Scutellariae Barbatae 95-115 part, Herba Hedyotidis Diffusae 95-115 part, fries Nidus Vespae 36-48 part, Squama Manis 74-94 part.
2. anticancer righting decoction liquid for oral administration according to claim 1, it is characterized in that: be made up of the crude drug of following parts by weight: Radix Codonopsis 84 parts, Rhizoma Atractylodis Macrocephalae (parched) 70 parts, 70 parts, Poria, fry Pericarpium Citri Reticulatae 70 parts, the Radix Astragali 210 parts, Radix Angelicae Sinensis 70 parts, the Radix Angelicae Dahuricae 70 parts, Herba Scutellariae Barbatae 105 parts, Herba Hedyotidis Diffusae 105 parts, fries 42 parts, Nidus Vespae, Squama Manis 84 parts.
3. an anticancer righting decoction liquid for oral administration, is characterized in that: be made up of the crude drug of following parts by weight: Radix Codonopsis 74-94 part, Rhizoma Atractylodis Macrocephalae (parched) 60-80 part, Poria 60-80 part, fries Pericarpium Citri Reticulatae 60-80 part, Radix Astragali 190-230 part, Radix Angelicae Sinensis 60-80 part, Radix Angelicae Dahuricae 60-80 part, Herba Scutellariae Barbatae 95-115 part, Herba Hedyotidis Diffusae 95-115 part, fries Nidus Vespae 36-48 part, Squama Manis 74-94 part, Rhizoma Dioscoreae Bulbiferae 74-94 part, Rhizoma Polygonati 116-136 part, Radix Salviae Miltiorrhizae 74-94 part, Eupolyphaga Seu Steleophaga 60-80 part, Pseudobulbus Cremastrae Seu Pleiones 60-80 part.
4. anticancer righting decoction liquid for oral administration according to claim 3, is characterized in that: be made up of the crude drug of following parts by weight: Radix Codonopsis 84 parts, Rhizoma Atractylodis Macrocephalae (parched) 70 parts, 70 parts, Poria, fries Pericarpium Citri Reticulatae 70 parts, the Radix Astragali 210 parts, Radix Angelicae Sinensis 70 parts, the Radix Angelicae Dahuricae 70 parts, Herba Scutellariae Barbatae 105 parts, Herba Hedyotidis Diffusae 105 parts, fries 42 parts, Nidus Vespae, Squama Manis 84 parts, Rhizoma Dioscoreae Bulbiferae 84 parts, Rhizoma Polygonati 126 parts, Radix Salviae Miltiorrhizae 84 parts, Eupolyphaga Seu Steleophaga 70 parts, Pseudobulbus Cremastrae Seu Pleiones 70 parts.
CN201410288392.6A 2014-06-25 2014-06-25 A kind of anticancer righting decoction liquid for oral administration Expired - Fee Related CN104013709B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410288392.6A CN104013709B (en) 2014-06-25 2014-06-25 A kind of anticancer righting decoction liquid for oral administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410288392.6A CN104013709B (en) 2014-06-25 2014-06-25 A kind of anticancer righting decoction liquid for oral administration

Publications (2)

Publication Number Publication Date
CN104013709A CN104013709A (en) 2014-09-03
CN104013709B true CN104013709B (en) 2015-12-30

Family

ID=51430892

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410288392.6A Expired - Fee Related CN104013709B (en) 2014-06-25 2014-06-25 A kind of anticancer righting decoction liquid for oral administration

Country Status (1)

Country Link
CN (1) CN104013709B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108992624A (en) * 2018-10-25 2018-12-14 林洪生 A kind of Chinese medicine composition and preparation method preventing tumor in digestive tract recurrence and transfer
CN109200248A (en) * 2018-11-20 2019-01-15 温州市中心医院 A kind of Chinese medicine composition for treating lymthoma
CN110101825A (en) * 2019-06-25 2019-08-09 张家港市力锦源科技发展有限公司 A kind of Chinese medicine for the treatment of cancer
CN110898202A (en) * 2019-12-04 2020-03-24 淮安市淮安医院 Biological medicine and medical food for digestive tract diseases and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1252300A (en) * 1999-10-10 2000-05-10 黄晓维 Compounding method of carcinomatosis resisting medicine
CN102274361A (en) * 2011-07-29 2011-12-14 李丰曹 Anticancer medicinal composition and preparation method of decoction thereof

Also Published As

Publication number Publication date
CN104013709A (en) 2014-09-03

Similar Documents

Publication Publication Date Title
CN101822806B (en) Traditional Chinese medicine composition for treating lung cancer and preparation method thereof
CN101972443B (en) Chinese medicinal formula for treating chronic gastritis
CN104013709B (en) A kind of anticancer righting decoction liquid for oral administration
CN103301400B (en) A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis
CN102284049A (en) Traditional Chinese medicine compound preparation for resisting ulcer and relieving chemoradiotherapeutic toxic and side effects, and preparation method and application thereof
CN103341150B (en) Traditional Chinese medicine preparation for treating chronic gastritis
CN102580000A (en) Medicament for curing cancer pain and preparation method thereof
CN104663989A (en) Soothing tea and preparation method thereof
CN100372558C (en) Medicine for treating leucocytopenia caused after tumor radiotherapy and chemotherapy
CN103251796B (en) Traditional Chinese medicine for treating insomnia
CN104288631A (en) Medicine composition for treating colon cancer and preparation method thereof
CN103356948B (en) A kind of medicine for the treatment of stomachache and preparation method thereof
CN102000181B (en) Chinese traditional medicine composition for treating diarrhea and method for preparing medicament from Chinese traditional medicine composition
CN108671165A (en) A kind of traditional Chinese herbal decoction for treating female climacteric syndrome
CN105079201B (en) A kind of sharp water plaster for the cirrhotic ascites that subsides
CN107753921B (en) Traditional Chinese medicine navel plaster for treating hyperemesis gravidarum
CN104688999A (en) Chinese herbal preparation for immunity enhancement
CN104623605A (en) Traditional Chinese medicine capable of treating breast cancer
CN104069396A (en) Traditional Chinese medicine for treating chemoradiotherapy-induced leukopenia
CN105079438B (en) A kind of pharmaceutical preparation for treating vital myocarditis
CN115845009B (en) Navel moxibustion medicinal powder for treating spleen deficiency diarrhea and application thereof
CN104491504B (en) A kind of Chinese medicine preparation for treating pleural effusion disease
CN102961662B (en) Medicine for treating gastric ulcer and preparation method thereof
CN103961391B (en) A kind of pharmaceutical composition treating gastrointestinal neurosis
CN107007787A (en) Treat the Chinese medicine of chronic gastritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C53 Correction of patent for invention or patent application
CB02 Change of applicant information

Address after: 250000, Ji'nan, Shandong West Industrial and Commercial Road Flyover District No. 2

Applicant after: Wang Zaifeng

Address before: 274300 Zhengda hospital, Shun teachers Road, Heze, Shandong, Shanxian County

Applicant before: Wang Zaifeng

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB02 Change of applicant information

Address after: 274300 Zhengda hospital, Shun teachers Road, Heze, Shandong, Shanxian County

Applicant after: Wang Zaifeng

Address before: 250000, Ji'nan, Shandong West Industrial and Commercial Road Flyover District No. 2

Applicant before: Wang Zaifeng

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 250000 JINAN, SHANDONG PROVINCE TO: 274300 HEZE, SHANDONG PROVINCE

C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Wang Zaifeng

Inventor after: Liu Yunjian

Inventor before: Wang Zaifeng

COR Change of bibliographic data
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151230

Termination date: 20160625

CF01 Termination of patent right due to non-payment of annual fee